Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment

Fig. 4

Kaplan–Meier survival curves comparing lung cancer patients with high and low expression of CLEC3B. a OS survival curves of all lung cancer patients (n = 1926), b ADC patients (n = 720), and c SCC patients (n = 524). d–f PFS survival curves of all lung cancer patients (n = 982), ADC patients (n = 461), and SCC patients (n = 141). OS, overall survival; PFS, progression-free survival; HR, hazard ratio; CI, confidence interval; ADC, adenocarcinoma; SCC, squamous cell carcinoma

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us